Replies to post #95336 on NanoViricides Inc. (NNVC)

[drkazmd65]

Yep,.... and that makes all the difference.

And that's one of the reasons that most investing here are still here - we're waiting on seeing what this company can do when they get to that stage.

[DaysOnTheBeach]

Right. And a $6B market cap. So yes, PUMA has clinical results, and the share price and market cap reflect that.

NNVC on the other hand is still a pre-clinical stage company, with a market cap what, about a 1/30th that of PUMA? So the NNVC market cap reflects your observation of no clinical results. And when NNVC enters into clinical trials and registers a few successes, will their market cap grow by 30:1 to match PUMA? I think so, yes.

best to all.